Onconova Therapeutics (ONTX) Reports Q2 Loss of $1.96/Share

August 15, 2016 7:02 AM EDT

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Onconova Therapeutics (NASDAQ: ONTX) reported Q2 EPS of ($1.96), versus ($4.13) reported last year. Revenue for the quarter came in at $2.25 million, versus $123 thousand reported last year.

For earnings history and earnings-related data on Onconova Therapeutics (ONTX) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment